Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma.
Marseglia M, Amaro A, Solari N, Gangemi R, Croce E, Tanda ET, Spagnolo F, Filaci G, Pfeffer U, Croce M. Marseglia M, et al. Among authors: solari n. Cancers (Basel). 2021 Apr 23;13(9):2043. doi: 10.3390/cancers13092043. Cancers (Basel). 2021. PMID: 33922591 Free PMC article. Review.
Neoadjuvant treatments in patients with high-risk resectable stage III/IV melanoma.
Spagnolo F, Croce E, Boutros A, Tanda E, Cecchi F, Mascherini M, Solari N, Cafiero F, Queirolo P. Spagnolo F, et al. Among authors: solari n. Expert Rev Anticancer Ther. 2020 May;20(5):403-413. doi: 10.1080/14737140.2020.1760847. Epub 2020 May 3. Expert Rev Anticancer Ther. 2020. PMID: 32326767 Review.
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting.
Vanni I, Pastorino L, Tanda ET, Andreotti V, Dalmasso B, Solari N, Mascherini M, Cabiddu F, Guadagno A, Coco S, Allavena E, Bruno W, Pietra G, Croce M, Gangemi R, Piana M, Zoppoli G, Ferrando L, Spagnolo F, Queirolo P, Ghiorzo P. Vanni I, et al. Among authors: solari n. Int J Mol Sci. 2023 Feb 21;24(5):4302. doi: 10.3390/ijms24054302. Int J Mol Sci. 2023. PMID: 36901733 Free PMC article.
The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086).
Tropea S, Del Fiore P, Maurichi A, Patuzzo R, Santinami M, Ribero S, Quaglino P, Caliendo V, Borgognoni L, Sestini S, Giudice G, Nacchiero E, Caracò C, Cordova A, Solari N, Piazzalunga D, Tauceri F, Carcoforo P, Lombardo M, Cavallari S, Mocellin S; Italian Melanoma Intergroup (IMI). Tropea S, et al. Among authors: solari n. BMC Cancer. 2022 Jun 3;22(1):610. doi: 10.1186/s12885-022-09705-y. BMC Cancer. 2022. PMID: 35659273 Free PMC article.
Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study.
Rossi CR, Mocellin S, Campana LG, Borgognoni L, Sestini S, Giudice G, Caracò C, Cordova A, Solari N, Piazzalunga D, Carcoforo P, Quaglino P, Caliendo V, Ribero S; Italian Melanoma Intergroup (IMI). Rossi CR, et al. Among authors: solari n. Ann Surg Oncol. 2018 Jan;25(1):271-279. doi: 10.1245/s10434-017-6143-5. Epub 2017 Oct 24. Ann Surg Oncol. 2018. PMID: 29067603
The role of sentinel lymph node biopsy in patients with stage I/II cutaneous melanoma. The clinical experience at the National Cancer Research Institute of Genoa, Italy.
Cafiero F, Gipponi M, Di Somma C, Solari N, Peressini A, Gliori S, Bassetti C, Spina B, Nicolò G, Schenone F, Castagnola F, Queirolo P, Sertoli MR. Cafiero F, et al. Among authors: solari n. Tumori. 2002 May-Jun;88(3):S55-6. doi: 10.1177/030089160208800347. Tumori. 2002. PMID: 12369556 No abstract available.
70 results